Hormone therapy, inclusion, and care for transgender patients in the field of laboratory medicine: Challenges and recommendations for a respectful approach. A systematic review
Resumen
OBJECTIVE: To show the laboratory care of trans people as part of clinical care, as well as the possible interactions between hormonal therapies (testosterone and estradiol) and relevant pharmacotherapies, with a focus on pre-exposure prophylaxis (PrEP) and antiretroviral therapies (ART). To explore the challenges faced by physicians in interpreting laboratory results for trans individuals on hormonal therapy and to report on the available strategies that can be used to interpret these results. METHODOLOGY: This is a narrative literature review in which 30 articles were found, 20 were excluded due to the exclusion criteria, theme. Period of time, plagiarism, sources, and only 10 were selected and used. RESULTS: The table shows the challenges faced by transgenic patients, of various types, from the family, hormone treatment, to specialized and welcoming care. CONCLUSION: We came to the conclusion that the interfering factors are diverse, from the lack of specialized staff, studies, reference values, to the form of care.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2023 Antoniel de Oliveira Soares, Sara Sofia Pereira Holanda, Marcos Rodrigo Miranda Duarte, Amanna Raquel Cunha de Almeida, Miquéias Lima Feitosa, Geovanna Pereira Costa, Marta Myllara de Paula Silva##plugins.themes.gdThemes.article.Authors##
-
Antoniel de Oliveira Soares
-
Sara Sofia Pereira Holanda
-
Marcos Rodrigo Miranda Duarte
-
Amanna Raquel Cunha de Almeida
-
Miquéias Lima Feitosa
-
Geovanna Pereira Costa
-
Marta Myllara de Paula Silva